Search

CorMedix Inc

Geschlossen

BrancheGesundheitswesen

7.84 -2.12

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

7.8100000000000005

Max

8.07

Schlüsselkennzahlen

By Trading Economics

Einkommen

25M

39M

Verkäufe

-1.2M

127M

KGV

Branchendurchschnitt

3.89

62.58

EPS

0.35

Gewinnspanne

30.293

Angestellte

191

EBITDA

-289K

66M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+73.91% upside

Dividenden

By Acuity

Nächstes Ergebnis

6. Aug. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

9.5M

610M

Vorheriger Eröffnungskurs

9.96

Vorheriger Schlusskurs

7.84

Nachrichtenstimmung

By Acuity

72%

28%

300 / 340 Ranking in Healthcare

CorMedix Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

24. Juli 2026, 17:56 UTC

CorMedix Inc's shares are declining, with no specific news identified. The stock remains below its 20-day moving average and near the lower end of its one-month range.

23. Juli 2026, 21:51 UTC

CorMedix Inc shares declined in after-market trading, moving lower despite broader market resilience and turmoil in the bond market. No specific news was identified.

22. Juli 2026, 23:11 UTC

CorMedix Inc. shares are higher in after-market hours, following notable activity. The stock remains below its 20-day moving average.

21. Juli 2026, 19:31 UTC

CorMedix Inc. shares are higher today, reflecting strong buying activity. The stock has gained momentum since Monday's close, despite remaining below its 20-day moving average.

20. Juli 2026, 22:01 UTC

CorMedix Inc shares are higher in after-market trading, reflecting a notable rise since Monday's close, despite being below its 20-day moving average.

Peer-Vergleich

Kursveränderung

CorMedix Inc Prognose

Kursziel

By TipRanks

73.91% Vorteil

12-Monats-Prognose

Durchschnitt 14 USD  73.91%

Hoch 15 USD

Tief 13 USD

Basierend auf 5 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für CorMedix Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

5 ratings

5

Buy

0

Halten

0

Sell

Stimmung

By Acuity

300 / 340 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
help-icon Live chat